19th Annual International Myeloma Society Meeting

Cecilia BrownMyeloma | November 16, 2022

Doris Hansen, MD, of the Moffitt Cancer Center, spoke about the research during an oral abstract presentation at IMS.

Leah SherwoodMeeting News | November 22, 2022

Adding a monoclonal antibody to a triplet treatment significantly lowered the risk of disease...

Leah SherwoodMyeloma | May 12, 2023

A single infusion of ciltacabtagene autoleucel “resulted in deep and durable responses" in CARTITUDE-2’s cohort A.

Leah SherwoodMyeloma | November 16, 2022

The data were from the phase III DETERMINATION trial...

Leah SherwoodMyeloma | November 16, 2022

Carfilzomib, lenalidomide, and dexamethasone improved progression-free survival (PFS) over...

Cecilia BrownMeeting News | November 22, 2022

Adding ixazomib to pomalidomide and dexamethasone improved progression-free survival rates...